ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company developing, manufacturing, and commercializing innovative and high-quality therapeutics as we transform into a leading Rare Disease company.
ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET
2026-04-24
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity
2026-04-20
$78.06
0 ( 0% )
Pricing delayed by 20 minutes
Last updated
2026-04-23 16:00:00